Elsevier

Ophthalmology

Volume 126, Issue 1, January 2019, Pages P286-P334
Ophthalmology

Preferred practice pattern
Dry Eye Syndrome Preferred Practice Pattern®

https://doi.org/10.1016/j.ophtha.2018.10.023Get rights and content

Section snippets

CORNEA/EXTERNAL DISEASE PREFERRED PRACTICE PATTERN® DEVELOPMENT PROCESS AND PARTICIPANTS

The Cornea/External Disease Preferred Practice Pattern® Panel members wrote the Dry Eye Syndrome Preferred Practice Pattern® guidelines (PPP). The PPP Panel members discussed and reviewed successive drafts of the document, meeting in person twice and conducting other review by e-mail discussion, to develop a consensus over the final version of the document.

Cornea/External Disease Preferred Practice Pattern Panel 2017–2018

Esen K. Akpek, MD

Guillermo Amescua, MD

Marjan Farid, MD

Francisco J.

FINANCIAL DISCLOSURES

In compliance with the Council of Medical Specialty Societies' Code for Interactions with Companies (available at www.cmss.org/codeforinteractions.aspx), relevant relationships with industry are listed. The Academy has Relationship with Industry Procedures to comply with the Code (available at www.aao.org/about-preferred-practice-patterns). A majority (70%) of the members of the Cornea/External Disease Preferred Practice Pattern Panel 2017–2018 had no financial relationships to disclose.

TABLE OF CONTENTS

  • OBJECTIVES OF PREFERRED PRACTICE PATTERN GUIDELINES P291

  • METHODS AND KEY TO RATINGS P292

  • HIGHLIGHTED FINDINGS AND RECOMMENDATIONS FOR CARE P293

  • INTRODUCTION P294

  • Disease Definition P294

  • Patient Population P294

  • Clinical Objectives P294

  • BACKGROUND P294

  • Prevalence and Risk Factors P294

  • Pathogenesis P296

  • Associated Conditions P297

  • Natural History P299

  • CARE PROCESS P299

  • Patient Outcome Criteria P299

  • Diagnosis P299

    • History P301

    • Examination P302

    • Diagnostic Tests P303

  • Classification of Dry Eye Syndrome P306

  • Management

OBJECTIVES OF PREFERRED PRACTICE PATTERN® GUIDELINES

As a service to its members and the public, the American Academy of Ophthalmology has developed a series of Preferred Practice Pattern® guidelines that identify characteristics and components of quality eye care. Appendix 1 describes the core criteria of quality eye care.

The Preferred Practice Pattern® guidelines are based on the best available scientific data as interpreted by panels of knowledgeable health professionals. In some instances, such as when results of carefully conducted clinical

METHODS AND KEY TO RATINGS

Preferred Practice Pattern® guidelines should be clinically relevant and specific enough to provide useful information to practitioners. Where evidence exists to support a recommendation for care, the recommendation should be given an explicit rating that shows the strength of evidence. To accomplish these aims, methods from the Scottish Intercollegiate Guideline Network1 (SIGN) and the Grading of Recommendations Assessment, Development and Evaluation2 (GRADE) group are used. GRADE is a

HIGHLIGHTED FINDINGS AND RECOMMENDATIONS FOR CARE

Dry eye is a common ocular condition that has a substantial impact on the quality of life of afflicted individuals owing to discomfort and visual disability. Dry eye may compromise results of corneal, cataract, and refractive surgery.

No single test is adequate for establishing the diagnosis of dry eye. The constellation of findings from multiple tests can add greatly to the clinician's understanding of the patient's condition.

Pharmacological and procedural treatments are associated with

DISEASE DEFINITION

Dry eye disease (also known as dry eye syndrome) refers to a group of disorders of the tear film that are due to reduced tear production or tear film instability, associated with ocular discomfort and/or visual symptoms and inflammatory disease of the ocular surface.

PATIENT POPULATION

The patient population includes individuals of all ages who present with symptoms and signs suggestive of dry eye, such as ocular irritation, redness, mucus discharge, fluctuating vision, and decreased tear meniscus or plugged

BACKGROUND

Dry eye, either alone or in combination with other conditions, is a frequent cause of ocular irritation that leads patients to seek ophthalmologic care.15 Even though these symptoms often improve with treatment, the disease usually is not curable, which may be a source of patient and physician frustration. Importantly, dry eye is also a cause of reduced visual function16, 17, 18, 19 and may compromise results of corneal, cataract, and refractive surgery.

PATIENT OUTCOME CRITERIA

Outcome criteria for treating dry eye include the following:

  • Reduce or alleviate signs and symptoms of dry eye, such as ocular irritation, redness, or mucous discharge

  • Maintain or improve visual function

  • Reduce or prevent ocular surface damage

DIAGNOSIS

Many ocular surface diseases produce symptoms that are similar to those associated with dry eye, including foreign body sensation, mild itching, irritation, and soreness. Identifying characteristics of the causative factors, such as adverse

APPENDIX 1. QUALITY OF OPHTHALMIC CARE CORE CRITERIA

Providing quality care is the physician's foremost ethical obligation, and is the basis of public trust in physicians.

AMA Board of Trustees, 1986

Quality ophthalmic care is provided in a manner and with the skill that is consistent with the best interests of the patient. The discussion that follows characterizes the core elements of such care.

The ophthalmologist is first and foremost a physician. As such, the ophthalmologist demonstrates compassion and concern for the individual, and utilizes

APPENDIX 2. INTERNATIONAL STATISTICAL CLASSIFICATION OF DISEASES AND RELATED HEALTH PROBLEMS (ICD) CODES

Dry eye includes entities with the following ICD-10 classifications:

ICD-10 CM
Dry eye, unspecified, right lacrimal glandH04.121
Dry eye, unspecified, left lacrimal glandH04.122
Dry eye, unspecified, bilateral lacrimal glandH04.123
Dry eye, keratoconjunctivitis sicca (not specified as Sjögren)H16.22-
Dry eye, Sjögren syndrome, Sicca syndromeM35.00
Dry eye, Sjögren syndrome, with keratoconjunctivitisM35.01

CM = Clinical Modification used in the United States; ICD = International Classification of

APPENDIX 3. SJÖGREN SYNDROME

Sjögren syndrome is defined as dry eye and dry mouth associated with systemic immune dysfunction. About 10% of patients with clinically significant dry eye have an underlying Sj□gren syndrome.57, 58 A significant proportion of the patients may not have been diagnosed at the time they present to the ophthalmology clinic with dry eye complaints.

Sj□gren syndrome is characterized by infiltration of the lacrimal and salivary glands with lymphocytes with secondary compromise of gland function.

APPENDIX 4. DIAGNOSTIC TESTS

This appendix summarizes the applicability of currently utilized tests to diagnose tear film and ocular surface disorders. These tests include the tear break-up time test to evaluate tear film stability, ocular surface dye staining to evaluate ocular surface disease, the Schirmer test and fluorescein disappearance test to evaluate aqueous tear production and clearance, and the tear osmolarity test.

LITERATURE SEARCHES FOR THIS PPP

Literature searches of the PubMed and Cochrane databases were conducted in March 2017; the search strategies were as follows. Specific limited update searches were conducted after June 2018.

Dry Eye Syndrome:

(“dry eye syndromes”[MeSH Terms] OR dry eye[tiab])

Epidemiology:

(“dry eye syndromes/epidemiology”[majr:noexp]) OR (“dry eye syndromes/ethnology”[majr:noexp]) OR ((dry eye[tiab) AND (prevalence[tiab] OR epidemiolog*[tiab] OR ethn*[tiab]))

Etiology:

(“dry eye syndromes/etiology”[majr:noexp]) OR

RELATED ACADEMY MATERIALS

Basic and Clinical Science Course

External Disease and Cornea (Section 8, 2018–2019)

Patient Education Brochure

Dry Eye (2014)

Spanish Language Brochure: Ojo Seco (2014)

Preferred Practice Pattern® Guidelines – Free download available at www.aao.org/ppp.

Comprehensive Adult Medical Eye Evaluation (2015)

Pediatric Eye Evaluations (2017)

First page preview

First page preview
Click to open first page preview

REFERENCES (203)

  • SC Pflugfelder

    Antiinflammatory therapy for dry eye

    Am J Ophthalmol

    (2004)
  • JA Seedor et al.

    Filamentary keratitis associated with diphenhydramine hydrochloride (Benadryl)

    Am J Ophthalmol

    (1986)
  • TH Mader et al.

    Keratoconjunctivitis sicca caused by diphenoxylate hydrochloride with atropine sulfate (Lomotil)

    Am J Ophthalmol

    (1991)
  • MT Bergmann et al.

    The effect of a diuretic (hydrochlorothiazide) on tear production in humans

    Am J Ophthalmol

    (1985)
  • DJ Browning et al.

    Ocular rosacea in blacks

    Am J Ophthalmol

    (1986)
  • JT Bamford et al.

    Childhood stye and adult rosacea

    J Am Acad Dermatol

    (2006)
  • AG Tzioufas et al.

    Update on Sjogren's syndrome autoimmune epithelitis: from classification to increased neoplasias

    Best Pract Res Clin Rheumatol

    (2007)
  • J Merayo-Lloves et al.

    Epstein-Barr virus dacryoadenitis resulting in keratoconjunctivitis sicca in a child

    Am J Ophthalmol

    (2001)
  • S Itescu

    Diffuse infiltrative lymphocytosis syndrome in human immunodeficiency virus infection–a Sjogren's-like disease

    Rheum Dis Clin North Am

    (1991)
  • JA Lucca et al.

    Keratoconjunctivitis sicca in male patients infected with human immunodeficiency virus type 1

    Ophthalmology

    (1990)
  • JP Craig et al.

    TFOS DEWS II Report executive summary

    Ocul Surf

    (2017)
  • JS Wolffsohn et al.

    TFOS DEWS II Diagnostic methodology report

    Ocul Surf

    (2017)
  • A Macri et al.

    A standardized visual scale for evaluation of tear fluorescein clearance

    Ophthalmology

    (2000)
  • OD Schein et al.

    Relation between signs and symptoms of dry eye in the elderly. A population-based perspective

    Ophthalmology

    (1997)
  • RL Chalmers et al.

    Dryness symptoms among an unselected clinical population with and without contact lens wear

    Cont Lens Anterior Eye

    (2006)
  • Scottish Intercollegiate Guidelines Network (SIGN)

    SIGN 50: a guideline developer's handbook

    (2015)
  • GH Guyatt et al.

    GRADE: an emerging consensus on rating quality of evidence and strength of recommendations

    BMJ

    (2008)
  • GRADE Working Group

    Organizations that have endorsed or that are using GRADE

  • The Dry Eye Assessment and Management Study Research Group

    n–3 Fatty acid supplementation for the treatment of dry eye disease

    N Engl J Med

    (2018)
  • M Straub et al.

    Long-term outcome after topical ciclosporin in severe dry eye disease with a 10-year follow-up

    Br J Ophthalmol

    (2016)
  • ED Donnenfeld et al.

    Safety of lifitegrast ophthalmic solution 5.0% in patients with dry eye disease: a 1-year, multicenter, randomized, placebo-controlled study

    Cornea

    (2016)
  • E Iglesias et al.

    Epidemiology of Persistent Dry Eye-Like Symptoms After Cataract Surgery

    Cornea

    (2018)
  • YJ Choi et al.

    Perioperative Ocular Parameters Associated With Persistent Dry Eye Symptoms After Cataract Surgery

    Cornea

    (2018)
  • E Zintzaras et al.

    The risk of lymphoma development in autoimmune diseases: a meta-analysis

    Arch Intern Med

    (2005)
  • Karakus SM, P.; Agrawal, D; Heinrich, C.; Ramulu, PY; Akpek, EH. Impact of Dry Eye on Prolonged Reading. Optometry and...
  • PM Mathews et al.

    Functional impairment of reading in patients with dry eye

    Br J Ophthalmol

    (2017)
  • MJ Sun et al.

    Impact of Glaucoma and Dry Eye on Text-Based Searching

    Transl Vis Sci Technol

    (2017)
  • SW van Landingham et al.

    Impact of dry eye on reading in a population-based sample of the elderly: the Salisbury Eye Evaluation

    Br J Ophthalmol

    (2014)
  • T Hikichi et al.

    Prevalence of dry eye in Japanese eye centers

    Graefes Arch Clin Exp Ophthalmol

    (1995)
  • SE Moss et al.

    Prevalence of and risk factors for dry eye syndrome

    Arch Ophthalmol

    (2000)
  • DA Schaumberg et al.

    Prevalence of dry eye disease among US men: estimates from the Physicians' Health Studies

    Arch Ophthalmol

    (2009)
  • MA Lemp et al.

    Distribution of aqueous-deficient and evaporative dry eye in a clinic-based patient cohort: a retrospective study

    Cornea

    (2012)
  • E Viso et al.

    Prevalence of and associated factors for dry eye in a Spanish adult population (the Salnes Eye Study)

    Ophthalmic Epidemiol

    (2009)
  • L Xu et al.

    Associations between gender, ccular parameters and diseases: The Beijing Eye Study

    Ophthalmic Res

    (2010)
  • SE Moss et al.

    Long-term incidence of dry eye in an older population

    Optom Vis Sci

    (2008)
  • EW Leung et al.

    Prevalence of ocular surface disease in glaucoma patients

    J Glaucoma

    (2008)
  • GC Rossi et al.

    Dry eye syndrome-related quality of life in glaucoma patients

    Eur J Ophthalmol

    (2009)
  • DA Schaumberg et al.

    Hormone replacement therapy and dry eye syndrome

    JAMA

    (2001)
  • OH Ababneh et al.

    Long-term efficacy and safety of botulinum toxin a injections to treat blepharospasm and hemifacial spasm

    Clin Experiment Ophthalmol

    (2014)
  • OK Ozgur et al.

    Dry eye syndrome due to botulinum toxin type-A injection: guideline for prevention

    Hawaii J Med Public Health

    (2012)
  • Cited by (0)

    View full text